Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for cancer and other major diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Astex Pharmaceuticals
Astex Pharmaceuticals is a company developing innovative therapies for the treatment of cancer.
Sector
Subsector
Keywords
Location
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company that develops cancer therapies using a drug ratio technology platform.
Sector
Subsector
Keywords
Location
total rounds
total raised
Tigris Pharmaceuticals
Tigris Pharmaceuticals develops therapeutic technologies for oncology and other medical needs.
Sector
Subsector
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Viracta Therapeutics
announced date
Financials
Funding Rounds10
Number of Funding Rounds
Money Raised
Their latest funding was raised on 01.07.2020. Their latest round Post-IPO Equity
Bridge Bank
Bridge Bank provides business banking products and services to small and middle-market businesses in the U.S.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors13
Number of lead investors
Number of investors
Alta Partners
Alta Partners is a venture capital firm investing in healthcare and life sciences.
Sector
Subsector
Location
count Of Investments
count Of Exists
Ed Hurwitz
Ed Hurwitz, an accomplished biotech executive and investor, is a Managing Director at MPM Capital and serves as Chairman of MPM portfolio companies BioIntervene and Rekindle Therapeutics and on the board of Dyne Therapeutics, also an MPM portfolio company. Prior to MPM, he was founder and Managing Director of Precision BioVentures where he founded and seeded start-up biotechnology companies, including Viewpoint Therapeutics. As a Director at Alta Partners, he led 12 successful investments including Applied Genetic Technologies Corporation, Avid Radiopharmaceuticals (acquired by Lilly), Calistoga Pharmaceuticals (acquired by Gilead), Cara Therapeutics, FoldRx Pharmaceuticals (acquired by Pfizer), MacroGenics and Taligen Therapeutics (acquired by Alexion). Over the course of his career, he has been a Senior Vice President and CFO of Affymetrix, a microarray pioneer, and a biotech research analyst for Robertson Stephens & Company and Smith Barney Shearson. He also practiced law at Cooley Godward LLP. Ed earned his J.D. and M.B.A. degrees from the University of California, Berkeley’s Boalt School of Law and Haas School of Business, and his B.A. in Molecular Biology from Cornell University.
current job
Rothschild & Cie
Rothschild Asset Management Inc. manages investments in various US securities.
Sector
Subsector
Keywords
count Of Investments
count Of Exists
Nextech Invest
Nextech Invest is a venture capital and private equity firm that focuses on precision therapies in oncology.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders1
James Wells
Jim Wells is Founder at Sunesis Pharmaceuticals.
current job
organization founded
James Wells
Employee Profiles55
Vicky Chang
Manager, sec reporting and technical accounting
Annette Pineda
Associate director, contracts administration-legal affairs